Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic, relapsing inflammatory ...
Patients with IBD who are prescribed opioids within a week of discharge from an emergency department or hospital are more ...
Women with inflammatory bowel disease (IBD) face increased pregnancy risks, often leading to confusion and fear. UCSF’s PIANO ...
Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV ...
Investor's Business Daily on MSN
Why IBD Stock Of The Day Medpace, Up 78% In 2025, Is Easily Outpacing Its Peers
Medpace is Tuesday's IBD Stock Of The Day. After a "staggering beat-and-raise quarter," Medpace stock has traded tightly for ...
Chromologics, a Danish biotech company developing fermentation-based natural colours, has raised €7 million from Novo Holdings, EIFO (the Export and Investment Fund of Denmark), Döhler Ventures, ...
Adults with IBD who achieved delayed remission by week 30 after starting advanced therapy had similar 1-year clinical and endoscopic outcomes as early remitters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback